These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11522237)

  • 1. Ex vivo purging of stem cell autografts using cytotoxic cells.
    Maki G
    J Hematother Stem Cell Res; 2001 Aug; 10(4):545-51. PubMed ID: 11522237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo purging with NK-92 prior to autografting for chronic myelogenous leukemia.
    Maki G; Tam YK; Berkahn L; Klingemann HG
    Bone Marrow Transplant; 2003 Jun; 31(12):1119-25. PubMed ID: 12796791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic methods of purging in autologous stem cell transplantation.
    Berkahn L
    J Hematother Stem Cell Res; 2000 Apr; 9(2):147-59. PubMed ID: 10813528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
    Klingemann HG; Wong E; Maki G
    Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ex vivo and in vivo purging for PBSCT].
    Moriyama Y
    Rinsho Byori; 1999 May; Suppl 110():79-84. PubMed ID: 10475035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of lymphokine-activated killer cells generated from bone marrow mononuclear cells for the purging of residual tumor cells in peripheral blood stem cell graft.
    Komatsu F; Kajiwara M
    Jpn J Cancer Res; 1996 Feb; 87(2):161-9. PubMed ID: 8609065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia.
    Scheffold C; Brandt K; Johnston V; Lefterova P; Degen B; Schöntube M; Huhn D; Neubauer A; Schmidt-Wolf IG
    Bone Marrow Transplant; 1995 Jan; 15(1):33-9. PubMed ID: 7538001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of hematopoietic cells and their clinical use.
    Aglietta M; Bertolini F; Carlo-Stella C; De Vincentiis A; Lanata L; Lemoli RM; Olivieri A; Siena S; Zanon P; Tura S
    Haematologica; 1998 Sep; 83(9):824-48. PubMed ID: 9825579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation.
    Thirukkumaran CM; Luider JM; Stewart DA; Cheng T; Lupichuk SM; Nodwell MJ; Russell JA; Auer IA; Morris DG
    Blood; 2003 Jul; 102(1):377-87. PubMed ID: 12637331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms.
    Long GS; Cramer DV; Harnaha JB; Hiserodt JC
    Bone Marrow Transplant; 1990 Sep; 6(3):169-77. PubMed ID: 2252956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ex vivo purging with CliniMACS CD34(+) selection on outcome after autologous stem cell transplantation in non-Hodgkin lymphoma.
    Yahng SA; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Park CW; Kim Y; Cho SG
    Br J Haematol; 2014 Feb; 164(4):555-64. PubMed ID: 24266323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is bone marrow purging proving to be of value?
    Gulati SC; Romero CE; Ciavarella D
    Oncology (Williston Park); 1994 Sep; 8(9):19-24; discussion 24, 29-32. PubMed ID: 7993723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.
    Gribben JG; Freedman AS; Neuberg D; Roy DC; Blake KW; Woo SD; Grossbard ML; Rabinowe SN; Coral F; Freeman GJ
    N Engl J Med; 1991 Nov; 325(22):1525-33. PubMed ID: 1944436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of photodynamic therapy in bone marrow purging.
    Mulroney CM; Glück S; Ho AD
    Semin Oncol; 1994 Dec; 21(6 Suppl 15):24-7. PubMed ID: 7992104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allograft and autograft purging using immunotoxins in clinical bone marrow transplantation for hematologic malignancies.
    Uckun FM; Myers DE
    J Hematother; 1993; 2(2):155-63. PubMed ID: 7921971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of lymphokine-activated killer (LAK) cells and possible implications in autologous bone marrow transplantation--a preliminary report.
    Tzeng CH; Chuang MW; Wang SY; Hsieh RK; Liu CJ; Fan S; Chen PM
    Proc Natl Sci Counc Repub China B; 1990 Jan; 14(1):47-53. PubMed ID: 2381997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological purging of breast cancer cell lines using a replication-competent oncolytic virus in human stem cell autografts.
    Thirukkumaran CM; Luider JM; Stewart DA; Alain T; Russell JA; Auer IA; Forsyth P; Morris DG
    Bone Marrow Transplant; 2005 Jun; 35(11):1055-64. PubMed ID: 15821774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.